We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+7.12%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$146M
AUM Growth
-$2.25M
Cap. Flow
-$1.85M
Cap. Flow %
-1.27%
Top 10 Hldgs %
49.44%
Holding
70
New
2
Increased
36
Reduced
2
Closed
8

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$2.36M
2
NEO icon
NeoGenomics
NEO
+$2.33M
3
NXTM
NxStage Medical Inc.
NXTM
+$2.16M
4
ELGX
Endologix Inc
ELGX
+$1.93M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$967K

Top Sells

Rank Stock Value
1
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
+$3.56M
2
NPSP
NPS PHARMACEUTICALS INC
NPSP
+$2.76M
3
GNMK
GenMark Diagnostics, Inc
GNMK
+$2.03M
4
LCI
Lannett Company, Inc.
LCI
+$1.63M
5
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$1.62M

Sector Composition

Rank Sector Weight
1 Healthcare 88.7%
2 Consumer Staples 1.01%
3 Financials 0.29%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLDX icon
26
Celldex Therapeutics
CLDX
$2.99B
$1.85M 1.27%
9,521
+231
+2% +$50.3K
VRTX icon
27
Vertex Pharmaceuticals
VRTX
$121B
$1.83M 1.25%
16,285
+436
+3% +$41.5K
HSTM icon
28
HealthStream
HSTM
$819M
$1.82M 1.25%
76,014
+2,093
+3% +$52.7K
LAB icon
29
Standard BioTools
LAB
$340M
$1.82M 1.25%
74,482
+2,031
+3% +$57.1K
CPHD
30
DELISTED
Cepheid Inc
CPHD
$1.82M 1.24%
41,272
+1,140
+3% +$48.1K
ALGN icon
31
Align Technology
ALGN
$12.1B
$1.75M 1.2%
33,934
+898
+3% +$48.9K
ABCO
32
DELISTED
Advisory Board Co
ABCO
$1.69M 1.15%
36,226
+972
+3% +$47.9K
LMAT icon
33
LeMaitre Vascular
LMAT
$2.32B
$1.67M 1.14%
242,968
+6,706
+3% +$50.1K
STKL
34
DELISTED
SunOpta
STKL
$1.48M 1.01%
122,576
+5,106
+4% +$67.3K
BMRN icon
35
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.47M 1%
20,325
+573
+3% +$37.7K
IONS icon
36
Ionis Pharmaceuticals
IONS
$8.6B
$1.06M 0.73%
+27,290
New +$967K
ANGO icon
37
AngioDynamics
ANGO
$611M
$958K 0.66%
69,822
+2,053
+3% +$29.3K
CYTK icon
38
Cytokinetics
CYTK
$10.5B
$581K 0.4%
165,046
+3,475
+2% +$14.6K
NVS icon
39
Novartis
NVS
$297B
$571K 0.39%
6,774
– –
ENDP
40
DELISTED
Endo International plc
ENDP
$558K 0.38%
8,161
– –
PETX
41
DELISTED
Aratana Therapeutics, Inc.
PETX
$539K 0.37%
53,667
+1,433
+3% +$17.4K
UTHR icon
42
United Therapeutics
UTHR
$25.8B
$491K 0.34%
3,820
– –
AGN
43
DELISTED
Allergan plc
AGN
$491K 0.34%
+2,035
New +$455K
ELV icon
44
Elevance Health
ELV
$81.5B
$490K 0.34%
4,095
– –
HUM icon
45
Humana
HUM
$43.7B
$461K 0.32%
3,540
– –
VTRS icon
46
Viatris
VTRS
$20.4B
$445K 0.3%
9,775
– –
BMY icon
47
Bristol-Myers Squibb
BMY
$133B
$424K 0.29%
8,290
– –
AET
48
DELISTED
Aetna Inc
AET
$422K 0.29%
5,215
– –
JNJ icon
49
Johnson & Johnson
JNJ
$618B
$407K 0.28%
3,820
– –
AZN icon
50
AstraZeneca
AZN
$263B
$406K 0.28%
5,680
– –
1
2
3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q3 2014 Portfolio in Review

As of Q3 2014, First Light Asset Management held 70 positions worth $146M, down 1.5% from $148M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

First Light Asset Management's Q3 2014 filing shows 2 new, 36 increased, 2 reduced and 8 closed positions. Its largest new stake was Ionis Pharmaceuticals: 27,290 shares worth $1.06M. The largest sale was VOCERA COMMUNICATIONS, INC., an estimated $3.56M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 83% a quarter earlier, followed by Consumer Staples and Financials.

  • First Light Asset Management's largest Q3 2014 buy was Ionis Pharmaceuticals: 27,290 shares worth $1.06M.
  • First Light Asset Management added most to Sanofi in Q3 2014, an estimated $2.36M increase.
  • First Light Asset Management's biggest Q3 2014 reduction was Lannett Company, Inc., cutting an estimated $1.63M.
  • First Light Asset Management fully exited VOCERA COMMUNICATIONS, INC. in Q3 2014, selling an estimated $3.56M.
  • First Light Asset Management's ten largest holdings make up 49% of its $146M portfolio in Q3 2014.
  • First Light Asset Management opened 2 new positions and closed 8 in Q3 2014.
  • First Light Asset Management's portfolio value fell 1.5% quarter-over-quarter to $146M.

Based on First Light Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.